Group 1 - The core point of the news is that Yidu Tech (02158) has been actively repurchasing its shares, with a recent buyback of over 880,000 shares at approximately HKD 5.65 per share, totaling around HKD 5 million, marking a new high for single-day repurchase amounts [1] - The company has conducted share buybacks for six consecutive trading days, with a cumulative repurchase amount nearing HKD 15 million, indicating a strong commitment to its buyback plan and confidence in its intrinsic value and long-term growth prospects [1] - The ongoing buyback activity is supported by the steady progress of Yidu Tech's AI healthcare business and the enhancement of its core competitiveness, highlighted by a strategic partnership with Nanshan People's Hospital in Shenzhen to develop an "AI + health management" system [1] Group 2 - Recent business achievements include surpassing 4.5 million insured individuals in the 2026 Beijing Universal Health Insurance project, demonstrating the company's strong capabilities in the healthcare service sector [2] - The launch of the "General Medicine Diagnosis AI Assistant" in collaboration with Chongqing Medical University First Affiliated Hospital has been trialed in over 20 grassroots medical institutions in Chongqing, creating a replicable digital healthcare solution [2] - Industry experts view the company's share repurchase as a positive signal for investors, reflecting confidence in profitability growth and quality improvement, which can help maintain the company's value and enhance investor expectations for future development [2]

1月28日，医渡科技(02158)再度发布股份回购公告，宣布当日以每股约6港元的价格回购12.18万股，耗 资约73万港元。至此，公司已连续4个交易日实施回购操作，合计回购约83万股，累计耗资近500万港 元，以持续的行动向市场传递信心。 在资本端积极释放信号的同时，医渡科技在业务拓展与产品落地方面也取得显著进展。28日消息，该公 司主运营的2026年度"北京普惠健康保"参保人数已突破450万。作为连续5年担任该项目主运营平台的企 业，医渡科技凭借专业的运营服务与技术赋能，持续助力首都多层次医疗保障体系建设，彰显了其业务 实力与市场认可度。 此外，公司在大模型医疗场景落地方面亦有新突破。由重庆医科大学附属第一医院全科医学科与医渡科 技联合开发的"全科医学诊疗AI助手"，自2025年5月上线试运行以来，已在重庆市20余家基层医疗机构 中投入应用，覆盖多个区县，累计服务医务人员超1000人次，逐步形成可复制、可推广的基层智慧医疗 解决方案。 ...

此外，公司在大模型医疗场景落地方面亦有新突破。由重庆医科大学附属第一医院全科医学科与医渡科 技联合开发的"全科医学诊疗AI助手"，自2025年5月上线试运行以来，已在重庆市20余家基层医疗机构 中投入应用，覆盖多个区县，累计服务医务人员超1000人次，逐步形成可复制、可推广的基层智慧医疗 解决方案。 智通财经APP获悉，1月28日，医渡科技(02158)再度发布股份回购公告，宣布当日以每股约6港元的价格 回购12.18万股，耗资约73万港元。至此，公司已连续4个交易日实施回购操作，合计回购约83万股，累 计耗资近500万港元，以持续的行动向市场传递信心。 在资本端积极释放信号的同时，医渡科技在业务拓展与产品落地方面也取得显著进展。28日消息，该公 司主运营的2026年度"北京普惠健康保"参保人数已突破450万。作为连续5年担任该项目主运营平台的企 业，医渡科技凭借专业的运营服务与技术赋能，持续助力首都多层次医疗保障体系建设，彰显了其业务 实力与市场认可度。 ...